D. Enders, T. Klumpen / Journal of Organometallic Chemistry 637–639 (2001) 698–709
703
4.00 (t, 1H, J=2.6 Hz, Cp-H), 4.26 (m, 4H, Cp-H),
4.55 (m, 1H, Cp-H), 4.92 (m, 1H, Cp-H), 6.85 (d, 2H,
J=8.0 Hz, C6H4), 7.03–7.11 (m, 2H, p-C6H5), 7.22 (t,
4H, J=7.7 Hz, m-C6H5), 7.35 (dt, 2H, J=8.2, 1.9 Hz,
C6H4), 7.70 (m, 4H, o-C6H5). 13C-NMR (C6D6, 100
MHz): l 20.94, 23.59, 27.14, 27.52, 55.61, 55.69, 58.88,
58.98, 66.64, 67.14, 68.44, 68.92, 71.38, 71.59, 71.64,
72.08, 74.68, 75.66, 76.58, 85.54, 88.31, 89.94, 127.48,
127.59, 127.72, 127.84, 127.97, 128.08, 129.53, 130.02,
135.25, 136.27, 138.60, 138.84, 144.87, 146.20. EIMS
(w), 1342 (m), 1322 (m), 1295 (m), 1283 (m), 1220 (m),
1197 (m), 1158 (m), 1106 (s), 1071 (s), 1023 (m), 1001
(w), 971 (m), 900 (m), 878 (w), 830 (m), 756 (vs), 723
(m), 698 (s), 667 (m), 636 (w), 525 (m), 499 (m), 481
1
(m), 457 (m). H-NMR (C6D6, 300 MHz): l 1.31 (m,
4H, NCH2CH2), 1.58 (m, 2H, N(CH2)2CHH), 1.89 (m,
2H, N(CH2)2CHH), 2.21 (m, 1H, NCHH), 2.60 (m,
3H, NCHH, OCHH), 2.82 (m, 1H, NCHH), 2.96 (m,
1H, NCHH), 3.04 (s, 3H, OCH3), 3.21 (s, 3H, OCH3),
3.40 (t, 1H, J=7.7 Hz, OCHH), 3.65 (m, 2H, OCHH,
NCH), 3.83 (m, 1H, NCH), 3.88 (br s, 1H, Cp-H), 4.29
(t, 1H, J=2.5 Hz, Cp-H), 4.43 (br s, 1H, Cp-H), 4.48
(br s, 1H, Cp-H), 4.90 (br s, 1H, Cp-H), 4.97 (br s, 1H,
Cp-H), 5.25 (br s, 1H, Cp-H), 6.95–7.27 (m, 14H,
p-C6H5, m-C6H5, o-C6H5), 7.72–7.93 (m, 6H, o-C6H5).
13C-NMR (C6D6, 75 MHz): l 23.43, 24.36, 26.97,
27.02, 55.17, 57.28, 58.65, 59.00, 64.99, 66.85, 69.17,
71.04, 73.75, 73.87, 73.94, 74.50, 75.33, 76.15, 76.50,
88.58, 94.10, 94.23, 127.14, 128.17, 128.23, 128.98,
129.52, 129.87, 130.34, 132.68 (d), 134.67 (d), 138.54,
139.34, 141.89, 146.77. The remaining aromatic signals
are covered by the solvent. 31P-NMR (C6D6, 162 MHz):
l 18.74 (s). 11B-NMR (C6D6, 160 MHz): l −34.47 (s).
EIMS (70 eV); m/z: (relative intensity, %)=691 (11),
(70 eV); m/z: (relative intensity, %) 743 ([M+ +2], 13),
+
742 ([M+ +1], 46), 741 ([M ], 100), 459 (12), 337
(12), 325 (13), 292 (14). Anal. Found: C, 69.31; H, 6.47;
N, 7.36. Calc. for C43H48FeN4O2S (740.79): C, 69.72;
H, 6.53; N, 7.56%.
4.9. [1,1%-Bis{N-[(2S)-2-(methoxymethyl)tetrahydro-
1H-1-pyrrolyl]-N-[(E)phenylmethylideneamino]}]-
[(Sp)-2-methylsulfanyl]ferrocene (3e)
According to GP1, a solution of the hydrazone 2
(563 mg, 0.91 mmol) in THF (15 ml) was first treated
n
with BuLi (1.25 ml, 2.0 mmol) and afterwards with
methyl disulfide (270 ml, 3.0 mmol). The hydrazone 3e
was obtained by aqueous work up and purification by
column chromatography on silica gel (pentane–Et2O
9:1).
690 (41), 689 ([M+ −C6H15NOB], 100), 406 (25), 337
(406−[C4H7N+], 37), 322 (28), 292 (406−[C6H12NO+
], 27), 287 (18). HRMS; m/z: 688.2182 (C48H54-
56FeBN4O2PꢀC6H15NOB; exact mass calc. for
C42H39 56FeN3OP: 688.2180).
Yield: 605 mg (100%, red powder); m.p.: 49 °C.
Rf=0.23 (pentane–Et2O 4:1). de]96%. [h]2D5= −53.1
(c=0.39, CHCl3). IR (CHCl3, cm−1): w 3080 (w), 3057
(w), 2972 (m), 2920 (m), 2874 (m), 2828 (m), 1565 (w),
1491 (m), 1460 (m), 1443 (m), 1386 (m), 1334 (m), 1296
(m), 1279 (m), 1263 (m), 1218 (m), 1196 (m), 1135 (m),
1111 (s), 1094 (s), 1072 (m), 1054 (m), 1024 (m), 970
(m), 924 (w), 902 (w), 892 (m), 876 (m), 823 (m), 757
(vs), 723 (m), 701 (s), 667(m), 520 (m). 1H-NMR (C6D6,
400 MHz): l 1.37 (m, 4H, NCH2CH2), 1.62 (m, 2H,
N(CH2)2CHH), 1.90 (m, 2H, N(CH2)2CHH), 2.14 (s,
3H, SCH3), 2.35 (m, 1H, NCHH), 2.46 (m, 1H,
NCHH), 2.79 (m, 2H, NCHH), 3.25 (s, 3H, OCH3),
3.31 (s, 3H, OCH3), 3.45 (t, 1H, J=8.8 Hz, OCHH),
3.64 (t, 1H, J=8.2 Hz, OCHH), 3.84 (m, 2H, OCHH),
3.98 (t, 1H, J=2.6 Hz, Cp-H), 4.05 (m, 1H, Cp-H),
4.07 (m, 2H, NCH), 4.15 (dd, 1H, J=2.5, 1.7 Hz,
Cp-H), 4.19 (m, 1H, Cp-H), 4.25 (m, 1H, Cp-H), 4.32
(m, 1H, Cp-H), 4.89 (m, 1H, Cp-H), 7.06–7.11 (m, 2H,
p-C6H5), 7.21 (t, 4H, J=7.7 Hz, m-C6H5), 7.69 (m, 4H,
o-C6H5). 13C-NMR (C6D6, 100 MHz): l 16.84, 23.46,
23.56, 27.30, 27.52, 55.52, 55.78, 58.97, 59.04, 66.62,
67.17, 67.29, 67.81, 69.69, 70.07, 70.13, 71.15, 72.81,
75.99, 76.53, 86.36, 88.64, 89.45, 127.59, 127.72, 127.84,
127.94, 129.41, 129.44, 138.56, 138.64, 146.32, 147.30.
4.8. [1,1%-Bis{N-[(2S)-2-(methoxymethyl)tetrahydro-
1H-1-pyrrolyl]-N-[(E)phenylmethylideneamino]}]-
[(Sp)-2-(4-methylphenyl)sulfanyl]ferrocene (3d)
According to GP1, a solution of the hydrazone 2
(563 mg, 0.91 mmol) in THF (15 ml) was first treated
n
with BuLi (1.25 ml, 2.0 mmol) and afterwards with
di-p-toluoyl disulfide (740 mg, 3.0 mmol). The hydra-
zone 3d was obtained by aqueous work up and purifica-
tion by column chromatography on silica gel
(pentane–Et2O 12:1).
Yield: 580 mg (86%, orange oil). Rf=0.20 (pentane–
Et2O 4:1). de]96%. [h]2D5= +395.2 (c=0.38, CHCl3).
IR (CHCl3, cm−1): w 3055 (w), 2971 (m), 2923 (m),
2873 (m), 2827 (m), 1597 (w), 1565 (w), 1492 (m), 1459
(m), 1445 (m), 1385 (m), 1339 (m), 1323 (m), 1296 (m),
1279 (m), 1218 (m), 1197 (m), 1113 (s), 1090 (s), 1072
(m), 1054 (m), 1024 (m), 970 (w), 891 (w), 877 (w), 812
(m), 803 (m), 757 (vs), 723 (m), 701 (m), 667 (w), 506
1
(m), 486 (m). H-NMR (C6D6, 400 MHz): l 1.34 (m,
4H, NCH2CH2), 1.62 (m, 2H, N(CH2)2CHH), 1.87 (m,
2H, N(CH2)2CHH), 2.05 (s, 3H, C6H4-CH3), 2.43 (m,
2H, NCHH), 2.76 (m, 2H, NCHH), 3.23 (s, 3H,
OCH3), 3.25 (s, 3H, OCH3), 3.45 (m, 2H, OCHH), 3.73
(dd, 2H, J=9.2, 3.7 Hz, OCHH), 3.90 (m, 2H, NCH),
EIMS (70 eV); m/z: (relative intensity, %) 667 ([M+
+
+
2], 13), 666 ([M+ +1], 43), 665 ([M ], 88), 422 (18),
400 (22), 399 (100), 391 (11), 383 (13), 369 (13), 368